Picture courtesy The Economic Times
New Delhi: The National Technical Advisory Group on Immunisation (NTAGI)’s Standing Technical Sub-Committee (STSC) has approved the use of COVID-19 vaccines Corbevax and Covaxin for children aged between five and 12 years, official sources said on Friday, news agency PTI reported. However, there was no decision on introducing these vaccines in the vaccination programme.
Data of Biological E’s Corbevax and Bharat Biotech’s Covaxin for children aged between five and 12 years were reviewed in the STSC meeting held on June 16. Members decided that the vaccines can be recommended for administration in children. The members, however, were of the view that data of COVID burden and mortality among children is not robust enough to take any decision to begin vaccination of those below 12 years, the report said quoting sources.
The issue is likely to be discussed in the next meeting. India’s drug regulator in April this year had granted emergency use authorisation to Corbevax for those aged five to 12 years and Covaxin for children in the age group of six to 12 years.
Bhubaneswar: The Biju Janata Dal (BJD) has appointed Nimapara MLA Samir Ranjan Dash as its…
Washington: Columbia University on Monday cancelled its university-wide graduation ceremony on May 15 following weeks…
Cuttack: In a rare order, the Orissa High Court has granted interim bail to the…
Bhubaneswar: Odisha players enjoyed a good day at the J30 ITF World Tennis Tour Juniors Meet…
Bhubaneswar: In a ground-breaking partnership, KIIT-DU and KPIT Technologies Ltd. have signed an MoU to…
Bhubaneswar: Odisha unit of BJP has approached the chief electoral officer (CEO) seeking action against…
New Delhi: As the Indian summer heats up and torments people of all ages, there’s…
Cuttack: The Orissa High Court has announced holiday for district courts on all four days…